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ABSTRACT
To prevent potential errors in protein synthesis,
some aminoacyl-transfer RNA (tRNA) synthetases
have evolved editing mechanisms to hydrolyze
misactivated amino acids (pre-transfer editing) or
misacylated tRNAs (post-transfer editing). Class Ia
leucyl-tRNA synthetase (LeuRS) may misactivate
various natural and non-protein amino acids and
then mischarge tRNA
Leu. It is known that the
fidelity of prokaryotic LeuRS depends on multiple
editing pathways to clear the incorrect intermedi-
ates and products in the every step of
aminoacylation reaction. Here, we obtained human
cytoplasmic LeuRS (hcLeuRS) and tRNA
Leu
(hctRNA
Leu) with high activity from Escherichia coli
overproducing strains to study the synthetic and
editing properties of the enzyme. We revealed that
hcLeuRS could adjust its editing strategy against
different non-cognate amino acids. HcLeuRS edits
norvaline predominantly by post-transfer editing;
however, it uses mainly pre-transfer editing to edit
a-amino butyrate, although both amino acids can be
charged to tRNA
Leu. Post-transfer editing as a final
checkpoint of the reaction was very important to
prevent mis-incorporation in vitro. These results
provide insight into the modular editing pathways
created to prevent genetic code ambiguity by
evolution.
INTRODUCTION
The aminoacyl-transfer RNA (tRNA) synthetases (aaRSs)
catalyze the activation of their cognate amino acids and
transfer them to the appropriate tRNA molecules (1).
Based on structural features, aaRSs can be divided into
two classes, I and II (2). Leucyl-tRNA synthetase (LeuRS)
falls into the ﬁrst category, which is characterized by the
HIGH and KMSK motifs. Structurally, all LeuRSs
contain a bipartite Rossmann-fold catalytic domain (3),
a large insertion domain called connective peptide 1
(CP1) within the catalytic domain (4), and a tRNA
anticodon-binding domain close to the C-terminus (5).
Furthermore, in the cytosol of higher eukaryotic cells,
human cytoplasmic LeuRS (hcLeuRS) exists as a compo-
nent of the multi-aminoacyl-tRNA synthetase complex
(MSC), which consists of eight aaRSs and three additional
non-synthetase accessory proteins (6). Similar to other
eukaryotic aaRSs (7), LeuRS has been linked to human
diseases. HcLeuRS is potentially implicated in lung
tumorigenesis (8), and the mitochondrial LeuRS may be
involved in diabetes (9).
The ﬁdelity of aaRSs is sometimes threatened by a
limited number of non-cognate standard amino acids.
For example, isoleucyl-tRNA synthetase (IleRS) must dis-
tinguish between isoleucine and valine, which differ by a
single missing methyl group (10,11). Valyl-tRNA
synthetase (ValRS) also activates threonine, which has a
hydroxyl group that is isosteric to the methyl moiety in
valine (12). Leucyl-tRNA synthetase (LeuRS), which is
homologous to IleRS and ValRS, misactivates a wide
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non-standard amino acids (13). To clear these mistakes
and maintain the ﬁdelity of protein synthesis (15), some
aaRSs have evolved editing mechanisms to hydrolyze
misactivated amino acids (pre-transfer editing) or
misacylated tRNAs (post-transfer editing). In addition,
the elimination of a non-cognate aminoacyl-adenylate
may occur through its preferential release and subsequent
hydrolysis in solution (kinetic proofreading) (16).
For example, IleRS performs pre- and post-transfer
editing reactions but prefers the pre-transfer pathway by
 80–90% (17). ValRS rejects threonine mainly by the
post-transfer pathway (12); however, whether or not
ValRS catalyzes via pre-transfer editing is still unknown.
Recent studies showed that LeuRS performs both pre-
and post-transfer editings, and the Escherichia coli
LeuRS favors post-transfer editing, whereas the Aquifex
aeolicus enzyme favors pre-transfer editing (18,19). Class
II aaRSs such as prolyl-tRNA synthetase (ProRS) (20),
alanyl-tRNA synthetase (AlaRS) (21) and
phenylalanyl-tRNA synthetase (PheRS) (22) all exhibit
both pre- and post-transfer editing, whereas threonyl-
tRNA synthetase (ThrRS) relies only on post-transfer
editing (23), while seryl-tRNA synthetase (SerRS)
performs only pre-transfer editing (24).
LeuRS, IleRS and ValRS form a subgroup of related
synthetases with high sequence and structural homology
(5). For post-transfer editing, a model was postulated
wherein the ﬂexible 30-end of a misacylated tRNA is
translocated from the aminoacylation active site to the
hydrolytic editing site (25,26). The non-cognate
aminoacyl-adenylates can be hydrolyzed via tRNA-
dependent (10,21,27) or tRNA-independent pathways by
LeuRS and other aaRSs (24,28). One possible model for
tRNA-dependent pre-transfer editing has been proposed
for IleRS and ValRS in which an initial post-transfer
editing step is used to trigger a conformational change
to an editing active conformation that can then perform
pre-transfer editing in the CP1 domain (29). This model
would require a migration of the adenylate from the syn-
thetic site to the editing site, which are separated by
 30A ˚ . However, there is no apparent channel between
the two sites, which could serve to prevent dissociation
of the adenylate from the surface of the enzyme during
translocation. On the other hand, several recent studies
have shown that tRNA-dependent pre-transfer editing
may occur in the synthetic active site. Class II ProRS
and SerRS edit non-cognate aminoacyl-adenylates in
their synthetic active site in a tRNA-independent way
(24,30). For the class I LeuRS, the location of a
tRNA-dependent pre-transfer editing activity within the
synthetic site was proposed (18). It was also shown that
class I GlnRS, which lacks an editing domain and any
known editing activity, is able to catalyze an editing-like
reaction in its synthetic active site (31).
Human cytoplasmic LeuRS (hcLeuRS) has been
identiﬁed as a component of the multi-aminoacyl-tRNA
synthetase complex (MSC) (32). It has been shown that
the C-terminal appended domain of hcLeuRS is crucial
for its interaction with other components of the MSC
(33). More recently, the editing properties of hcLeuRS
were reported (34). Substitution of the crucial threonine
residue from the CP1 editing domain did not induce the
usual discriminating effect on the non-cognate amino
acids, suggesting that the architecture of the editing site
is different from that of other characterized LeuRSs (34).
In the present study, recombinant human cytoplasmic
tRNA
Leu (hctRNA
Leu) and hcLeuRS were over-expressed
and puriﬁed from their E. coli transformants, separately.
With the puriﬁed hctRNA
Leu as substrate, hcLeuRS ex-
hibited much higher aminoacylation and editing activities
than those measured previously with tRNA transcript. We
found that hcLeuRS can misactivate several Leu analogs,
including norvaline (Nva), a-amino butyrate (ABA), Met
and Ile. We also show that hcLeuRS can charge
hctRNA
Leu with these amino acids and excluded the in-
correct products by multiple editing pathways. These
results showed that the human enzyme edits Nva essen-
tially by the post-transfer editing pathway occurring in the
CP1 domain. In contrast, editing of mis-activated ABA
mainly occurred at the pre-transfer stage, suggesting the
mechanical differences between editing pathways confers
an advantage for effective proofreading.
MATERIALS AND METHODS
Materials
L-leucine, L-isoleucine, L-valine, L-methionine,
L-norvaline, a-amino butyric acid (ABA), 50-GMP,
ATP, GTP, CTP, UTP, tetrasodium pyrophosphate, and
inorganic pyrophosphatase were purchased from Sigma
(St. Louis, MO, USA). L-[
3H]leucine and L-
[
3H]methionine (1mCi/ml) were obtained from Perkin
Elmer Life Sciences (Boston, MA, USA). T4 polynucleo-
tide kinase, T4 DNA ligase, RNasin (ribonuclease inhibi-
tor), isopropyl b-D-thiogalactoside (IPTG) and all
restriction endonucleases were obtained from Sangon
Co. (Shanghai, China). AN2690 was obtained from
Milestone Pharmtech USA Inc. GF/C and DE-81 ﬁlters
were obtained from the Whatman Co. (Dassel, Germany),
E. coli strain Rosetta
TM 2 (DE3) was purchased from
Novagen, EMD Biosciences Inc. (Darmstadt, Germany).
Plasmid pTrc99B, the gene encoding tRNA nucleotidyl-
transferase and E. coli strain MT102 were from the
Institut de Biologie Mole ´ culaire et Cellulaire du CNRS
(Strasbourg, France). The tRNA nucleotidyltransferase
was puriﬁed by the method described earlier (35).
Enzymes and tRNA preparations
The gene encoding hcLeuRS was PCR-ampliﬁed from
pFastBac1H-hcleus (33) and cloned between the NdeI
and SalI sites of pET22b(+). For overexpression, E. coli
strain Rosetta
TM 2 (DE3) was used. Typically, 500ml of
2 YT medium supplemented with 60mg/ml chloram-
phenicol, 100mg/ml ampicillin were inoculated and
incubated at 37 C until IPTG addition (200mM).
Induction was performed at 20 C for 6h. The puriﬁcation
of hcLeuRS on Ni
2+–NTA Superﬂow column (Qiagen
Inc., Germany) was carried out as described earlier (33).
hctRNA
Leu (in this study refers to hctRNA
Leu
CAG
isoacceptor) was either extracted from cells or prepared
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was puriﬁed from E. coli cells (strain MT102) containing
the gene encoding hctRNA
Leu as described earlier (36,37).
After incubation with IPTG at 37 C for 15h, the har-
vested cells were extracted by phenol and the nucleic
acid fraction was collected followed by loading onto a
DEAE-Sepharose CL-6B column (2 20cm). The
column was eluted with a linear NaCl gradient, while
the highest peak containing the tRNA
Leu was collected
and precipitated by ethanol. The tRNA sample from
DEAE-Sepharose was further applied to a 25ml C4
reversed-phase HPLC column (1 15cm) equilibrated
previously with buffer A (10mM NaH2PO4,1 M
NaHCO2, 8mM MgCl2, pH 5.5). The retained material
was eluted with programmed gradients of buffer A and B
(10mM NaH2PO4, 10% ethanol, pH 5.5) and recovered
by ethanol precipitation. In vitro transcription of
hctRNA
Leu and subsequent refolding of tRNA were per-
formed as described earlier (33). The tRNA concentration
was determined by UV absorbance at 260nm and the ex-
tinction coefﬁcient was calculated from the sequence of
each tRNA (38).
Amino acid activation
For hcLeuRS, the ATP-PPi exchange reaction was
performed at 37 C in a reaction mixture containing
2mM [
32P]pyrophosphate (PPi) 15cpm/pmol, 100mM
HEPES-KOH (pH 7.6), 6mM MgCl2, 2mM KF, 2mM
ATP, various concentrations of leucine (or Nva, or ABA,
or Ile or Met) and 80nM of hcLeuRS (37).
AMP formation
For hcLeuRS, AMP formation was measured in reaction
mixtures containing 1mM spermine, 50mM
HEPES-KOH (pH 7.6), 25mM KCl, 6mM MgCl2,
5mM DTT, 5U/ml PPase, 3mM ATP, 20nM
[a-
32P]ATP (3000Ci/mmol, Perkin Elmer) and 2mM
Leu, or 10mM Nva or 15mM ABA, with or without
5mM of overproduced tRNA
Leu. Reactions were
incubated at 37 C and initiated by 1mM hcLeuRS, or
the corresponding mutants in the presence of the amino
acid. Aliquots (1.5ml) were quenched in 6ml of 200mM
sodium acetate (pH 5.0). Quenched aliquots (1.0ml each)
were spotted in duplicate on polyethyleneimine cellulose
plates (Merck) pre-washed with water. Separation of AA-
[
32P]AMP, [
32P]AMP and [
32P]ATP was performed by de-
veloping TLC plates in 0.1M ammonium acetate and 5%
acetic acid (39). The plates were visualized by phosphor
imaging and the data were analyzed using ImageQuant 5.2
software (GE Healthcare). The gray densities of [
32P]AMP
and AA-[
32P]AMP spots were compared to the gray
density of a known [
32P]ATP concentration.
Aminoacylation and deacylation
The aminoacylation assay was carried out in a buffer con-
taining 1mM spermine, 50mM HEPES-KOH (pH 7.6),
25mM KCl, 6mM MgCl2,2 0 mM[
3H]Leu or 75mM
[
3H]Met, 4mM ATP, 10mM tRNA
Leu and 25nM
hcLeuRS or 1.5mM hcLeuRS-D399A mutant at 37 C.
Deacylation assays were performed at 37 C in reactions
identical to the aminoacylation condition except that the
amino acid and tRNA were replaced by 1mM
[
3H]Met-tRNA
Leu.
To determine the misacylation of non-cognate amino
acids by hcLeuRS mutant, reactions were performed as
described earlier (40,41). HctRNA
Leu was labeled at the
30-terminal internucleotide linkage using the exchange
reaction catalyzed by tRNA nucleotidyltransferase.
Reactions contained 50mM Tris–HCl buffer (pH 8.0),
12mM MgCl2, 5mM DTT, 3mM hctRNA
Leu, 0.5mM
[a-
32P]ATP (3000Ci/mmol, Perkin Elmer) and 3mM
tRNA nucleotidyltransferase. After incubation at 37 C
for 5min, yeast pyrophosphatase (PPase, Roche) was
added to a ﬁnal concentration of 10U/ml, and the
reaction mixture was incubated for an additional 2min
before quenching by phenol extraction.
Incorporation of unlabeled Leu, Nva or ABA amino
acids onto 30-
32P-labeled tRNA
Leu was measured by
aminoacylation assays which were identical to those
described above except that 5mM Leu, 10mM Nva or
15mM ABA was used. After aminoacylation, all reactions
were stopped and products digested by placing 1mlo f
reaction mixture in a buffer containing 200mM sodium
acetate (pH 5.0) and 0.2U/ml P1 nuclease (Fluka) and
incubating for 10min at 25 C. 30-aminoacylated A76
from aminoacylated tRNA and AMP from uncharged
tRNA were separated by TLC and quantiﬁed by
phosphorimaging analysis as described above (41).
RESULTS
Overexpression of hcLeuRS and hctRNA
Leu in E. coli
improves aminoacylation
In our earlier study, the gene encoding hcLeuRS was ex-
pressed in insect cells (33). Here, we cloned the human
gene into the plasmid pET22b in order to overexpress
the protein in E. coli with an Ala3-His6 tag at the
C-terminus. From 1.5g of wet cells, about 2mg of
hcLeuRS were obtained. The enzyme was puriﬁed to
90% homogeneity with a molecular mass of 135kDa,
which was similar to the one puriﬁed from the baculovirus
system (33). HcLeuRS overexpressed in E. coli exhibited
the same kcat values as the one overexpressed in insect cells
and reached around 0.3s
 1 with the transcript of
hctRNA
Leu (Table 1).
In an attempt to improve the kcat value of the
aminoacylation reaction, hctRNA
Leu was cloned in the
bacterial expression vector pTrc99B (36,37) in order to
produce a tRNA containing the base modiﬁcations that
are often essential for tRNA structure and stability. After
E. coli transformation and IPTG induction, 34mg of
crude tRNA were isolated from 6g of wet cells by the
standard phenol extraction procedure. This tRNA ex-
hibited a leucine-accepting activity of 864pmol/A260 with
hcLeuRS but only 103pmol/A260 with E. coli LeuRS
(EcLeuRS) (data not shown). After fractionation of the
total tRNA by DEAE-Sepharose chromatography, the
leucylation activity of the tRNA was improved to
Nucleic AcidsResearch, 2011, Vol.39,No. 1 2371450pmol/A260, and then to 1600pmol/A260 via further
fractionation on a C4 reversed-phase HPLC column.
Finally, about 4.5mg of nearly 100% pure hctRNA
Leu
were obtained starting from 6g of wet cells. The isolated
hctRNA
Leu had more thermal stability as the melting
point of the hctRNA
Leu was 15 C higher than that of its
transcript (data not shown).
In the aminoacylation reaction catalyzed by hcLeuRS,
the recombinant hctRNA
Leu that was overexpressed and
puriﬁed in E. coli was the most efﬁcient substrate. The kcat
value (2.56s
 1) for hctRNA
Leu isolated from E. coli was
9.1-, 7.8- and 5.7-fold higher compared to that of crude
calf liver tRNA (0.28s
 1), hctRNA
Leu transcript
(0.33s
 1), and EctRNA
Leu (0.45s
 1), respectively. The
Km value was the lowest among the four kinds of
tRNA
Leus and the catalytic efﬁciency of the present
hcLeuRS for hctRNA
Leu was 23-, 10- and 4-fold higher
compared to those above tRNA
Leus, respectively
(Table 1). Thus, the expression of both human LeuRS
and tRNA
Leu in E. coli led to a system with an efﬁciency
that is comparable to that of the EcLeuRS for EctRNA
Leu
(14). Overall, these results showed that the overexpressed
hctRNA
Leu is a competent substrate of hcLeuRS for the
aminoacylation and editing study.
We also analyzed the Michaelis constants of hcLeuRS
overexpressed in E. coli for Leu and ATP in the
aminoacylation reaction and compared them with those
from the enzyme expressed in baculovirus (33). Although
the kcat values were nearly the same, the KM values for Leu
and ATP were both reduced, showing that the enzyme
binds more tightly to these substrates. This resulted in
an increase of the catalytic efﬁciency (kcat/KM) in the
aminoacylation reaction of 60.4-fold for ATP and
22.6-fold for Leucine (Table 2), conﬁrming that the
enzyme overexpressed in E. coli has a robust activity
and is ideal for subsequent studies.
HcLeuRS misactivates several non-cognate amino acids
It has been shown previously that Ile and Met as well as
the non-standard amino acids norvaline (Nva) and
a-amino butyrate (ABA) are misactivated by LeuRS
(5,14,42,43). Among them, ABA is the smallest molecule
and Nva is the analog most similar to Leu. The kinetic
parameters of hcLeuRS for these various amino acids
were determined in the activation reaction; however, the
Mg
2+/ATP ratio was optimized and increased from 0.5
(33) to 3 prior to performing the assays. Consequently,
this resulted in an increase of the kcat from 0.8 to
25.8s
 1, a value much higher than the recently published
value of 2.1s
 1 (measured with an Mg
2+/ATP ratio of 10)
(34). The non-cognate amino acid activation assays
showed that Ile and Met were poorly activated by the
human enzyme (Table 3). In the present work, the
misactivation frequency for Ile was lower than the mis-
translation frequency (1/3300) in protein biosynthesis
(44), suggesting hcLeuRS would not require an editing
mechanism to prevent mischarging of this amino acid.
On the other hand, Met was more efﬁciently misactivated
by hcLeuRS, indicating that the amino acid should be
edited in vivo to prevent mis-incorporation into nascent
proteins (Table 3).
Among the non-standard amino acids, Nva was the
most efﬁciently misactivated compound. HcLeuRS to
Nva exhibited discrimination factors of about 100
compared to Leu. The kcat for Nva activation decreased
only about half of that for Leu, and the main effect was a
48-fold increase of KM as compared with for Leu. The kcat
value for ABA misactivation was much higher than those
for Ile and Met, and was only 6.6-fold lower than that of
Leu. However, the catalytic efﬁciency was quite low
because of the very high KM value of hcLeuRS for
ABA, which was about 800-fold of that for Leu
(Table 3). Altogether, these data showed that the synthetic
site of hcLeuRS could accommodate various non-cognate
amino acids. This also suggests that the enzyme might
have evolved proofreading pathways to get rid of
misactivated compounds to prevent genetic code
ambiguity.
Table 1. Kinetic constants of hcLeuRS for various tRNA
Leu
s in the aminoacylation reaction
Constants Calf liver tRNA
Leu
(50pmol/A260)
a
In vitro transcribed
hctRNA
Leu
(680pmol/A260)
Overexpressed EctRNA
Leu
(1400pmol/A260)
Overexpressed hctRNA
Leu
(1600pmol/A260)
KM (mM) 1.9±0.2 1.02±0.04 0.58±0.02 0.74±0.05
kcat (s
 1) 0.28±0.02 0.33±0.01 0.45±0.04 2.56±0.20
kcat/KM (s
 1 mM) 147.4 323.5 775.9 3459.5
aValues from Ling et al. (2005).
All data in this table are the average values from three independent determinations.
Table 2. Kinetic constants of hcLeuRS obtained from E. coli and
baculovirus in the aminoacylation reaction
Substrates Constants hcLeuRS
(from E. coli)
hcLeuRS
a
(from baculovirus)
Leucine KM (mM) 2.97±0.07 7.5±0.2
kcat (s
 1) 2.69±0.03 0.30±0.04
kcat/KM (s
 1 mM) 905.7 40
ATP KM (mM) 112.1±2.1 773±70
kcat (s
 1) 2.37±0.03 0.27±0.01
kcat/KM (s
 1 mM) 21.14 0.35
aValues from Ling et al. (2005).
All data in this table are the average values from three independent
determinations.
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Each time that a non-cognate amino acid is activated by
LeuRS and then hydrolyzed, one molecule of ATP is
transformed into AMP. Successive rounds of activation/
editing lead to accumulation of AMP molecules that can
be tracked by thin layer chromatography (TLC). TLC can
also be used to monitor the aminoacyl-adenylate forma-
tion (41). To perform the editing assay, enzymes were
incubated with a-[
32P]ATP, non-cognate amino acid and
tRNA
Leu. Aliquots of the editing mixtures were quenched
and applied on PEI TLC plates and the [
32P]AMP forma-
tion rates for hcLeuRS and mutant derivatives were
calculated (Figure 1, Table 4). In the assay, cognate Leu
induced a very low level of AMP, which is in agreement
with the fact that Leu is activated but not edited by LeuRS
(Supplementary Figure S1).
Editing of Nva was ﬁrst assayed because of its relatively
high misactivation rate compared with Ile and Met. In the
absence of tRNA, the AMP formation rate with Nva
reached 0.119s
 1. In theory, this AMP formation corres-
ponded mainly to the tRNA-independent pre-transfer
editing activity, which was added to the very low level of
spontaneous hydrolysis of the released adenylate mol-
ecules (1.63 10
 4s
 1, Supplementary Figure S2). The
presence of tRNA
Leu in the activation reaction mix
stimulated the AMP formation by about 13-fold
(1.57s
 1). This showed that hcLeuRS carried a strong
tRNA-dependent editing activity that represented more
Figure 1. Formation of [
32P]AMP and AA-[
32P]AMP catalyzed by hcLeuRS. Reactions were performed with (A) Nva or (B) ABA, in the absence
(-tRNA
Leu) or presence (+tRNA
Leu) of tRNA
Leu. The graphs represent the quantiﬁcation of the AMP formation in the presence of tRNA
Leu (open
circle) and in its absence (closed circle).
Table 3. Kinetic constants of wild-type and D399A mutant of hcLeuRS in amino acid activation reaction
hcLeuRS Amino Acids KM (mM) kcat (s
 1) kcat/KM (s
 1 mM
 1) Discrimination factor
a
WT Leu 45.6±9.5 25.8±1.5 565 1
Ile 1248±254 0.162±0.028 0.13 4346
Met 1547±334 0.474±0.130 0.31 1823
Nva 2195±68 12.4±0.5 5.65 100
ABA 36200±2600 3.91±0.15 0.108 5231
D399A Leu 50.0±8.8 26.2±0.9 524 1
Nva 5135±553 13.7±1.9 2.67 196
ABA 49440±7350 4.1±0.1 0.083 6313
aCorresponds to the loss of catalytic efﬁciency relative to Leu.
The data are the average values from three independent experiments.
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sistent with the values obtained with Aquifex aeolicus
LeuRS and Nva under the same conditions (28,45).
The TLC plates also revealed the accumulation of
Nva-AMP in the absence of tRNA
Leu when the enzyme
only exhibited tRNA-independent pre-transfer editing
(Figure 1A, Table 4). The concentration of Nva-AMP
exceeded the enzyme concentration, suggesting that it
resulted from multiple turnovers and release in solution.
However, when tRNA
Leu was present, Nva-AMP no
longer accumulated, indicating that it was more efﬁciently
edited after its transfer onto the tRNA, or alternatively by
tRNA-dependent pre-transfer editing.
Separation of the Nva-editing pathways
To investigate more thoroughly the editing pathways of
Nva and to separate the AMP formation resulting from
post-transfer editing and tRNA-dependent pre-transfer
editing, two additional assays were performed.
First, AMP formation assays were performed in the
presence of the recently identiﬁed benzoxaborole
antifungal compound AN2690. This molecule targets
LeuRS speciﬁcally by forming a covalent adduct with
the 30-adenosine of tRNA
Leu at the post-transfer editing
site (46,47). In that complex, tRNA is locked in an
inactive conformation for aminoacylation and
post-transfer editing (46,47) while both tRNA-dependent
or -independent pre-transfer editing pathways are kept
intact. In the present work, AN2690 was tested against
human LeuRS and was shown to inhibit Leu-tRNA
Leu
formation as previously observed for fungal LeuRSs (46)
and E. coli LeuRS (19). With 100mM of AN2690, the
aminoacylation activity of hcLeuRS was considerably
reduced and the charging plateau did not reach 20%
(Figure 2A). Similarly, the hydrolytic capacity of
mischarged Met-tRNA
Leu was drastically reduced in the
presence of AN2690 (Figure 2B). These effects were con-
sistent with the previous results and conﬁrmed that
locking the tRNA acceptor end into the editing site was
deleterious for both aminoacylation and post-transfer
editing activities. In contrast, when AMP formation was
measured in editing conditions in the presence of Nva and
AN2690, a stimulation of AMP formation was observed
by the tRNA (0.252s
 1) compared to the reaction without
tRNA (0.116s
 1) (Table 4, Figure 2C and D). This
suggests that a tRNA-dependent editing pathway was
still active in the presence of AN2690, and this pathway
should be a pre-transfer pathway since the acceptor end of
the tRNA was locked in an inactive conformation. This
also showed that tRNA binding in the editing site is
required for tRNA-dependent pre-transfer editing, a con-
clusion already reached with a study previously performed
on E. coli LeuRS (19).
Second, a CP1 mutation was used to abolish the
post-transfer editing pathway. Residue D399 in
hcLeuRS is conserved amino acid residue, which is hom-
ologous to D345 in E. coli (48), D419 in yeast cytoplasmic
LeuRS (ycLeuRS) (49), and D373 in A. aeolicus LeuRS
(AaLeuRS) (28). In Thermus thermophilus LeuRS, this
Asp residue forms salt bridge interactions with the
amino group of the Nva moiety in both the pre- and
post-transfer analogs (48). In LeuRSs, the mutation of
this invariant Asp residue inactivated the post-transfer
editing (28,34,49). We mutated the conserved D399 to A
of hcLeuRS to obtain hcLeuRS-D399A and measured
the amino acid activation, tRNA charging, and editing
activities of the D399A mutant. HcLeuRS-D399A
had full activity in the amino acid activation of Leu
(Table 3). Post-transfer editing activity of hcLeuRS-
D399A was also determined by the deacylation of [
3H]-
Met-tRNA
Leu. In 2min, wild-type hcLeuRS (25nM)
deacylated 60% of the Met-tRNA
Leu; however, the
D399A failed to hydrolyze Met-tRNA
Leu under the
same conditions (Figure 3A) (28,34,49). This obvious
loss of post-transfer editing activity of hcLeuRS-D399A
was accompanied by an increase of the misacylation
activity compared with the wild-type hcLeuRS
(Figure 3B). Taken together, these results indicated that
the conserved Asp residue is absolutely crucial for
Table 4. Observed steady-state constants of hcLeuRS and its D399A mutant in AMP and aa-AMP synthesis reaction
hcLeuRS Amino acids tRNA
Leu AN2690 AMP formation kobs (s
 1) AA-AMP formation kobs (s
 1)
WT Nva    (1.19±0.12) 10
 1 (1.21±0.12) 10
 2
Nva +   1.57±0.08 nd
Nva   + (1.16±0.09) 10
 1 (1.29±0.19) 10
 2
Nva + + (2.52±0.31) 10
 1 (0.46±0.08) 10
 2
Leu    (5.27±0.68) 10
 3 nd
Leu +   (9.85±1.31) 10
 3 nd
ABA    (3.19±0.28) 10
 2 (3.27±0.41) 10
 3
ABA +   (8.69±1.11) 10
 2 nd
ABA   + (3.47±0.24) 10
 2 (3.77±0.83) 10
 3
ABA + + (7.82±1.72) 10
 2 nd
D399A Nva    (9.91±2.10) 10
 2 (0.71±0.13) 10
 2
Nva +   (1.03±0.25) 10
 1 (0.72±0.09) 10
 2
ABA    (1.31±0.33) 10
 2 (5.46±1.09) 10
 4
ABA +   (3.11±0.87) 10
 2 (2.09±0.28) 10
 3
Data in this table are the average values from three independent determinations.
nd: not detected.
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since a signiﬁcant amount of mis-charged tRNA is formed
by its mutation. This is consistent with previously reported
studies with AaLeuRS, hcLeuRS, EcLeuRS and ycLeuRS
(28,34,48,49). Furthermore, the AMP formation catalyzed
by wild-type LeuRS and the mutant hcLeuRS-D399A
were assayed in editing conditions. The AMP formation
rate catalyzed by hcLeuRS-D399A was almost the same as
that of the wild-type enzyme (kobs 0.0991s
 1 versus
0.119s
 1) with Nva and in the absence of tRNA
(Figure 4A, Table 4). Therefore, the CP1-mutation did
not change the tRNA-independent editing process. In
the presence of tRNA and Nva, AMP formation by
hcLeuRS-D399A was only increased slightly as
compared with that without tRNA (kobs 0.103s
 1 and
0.0991s
 1, respectively), indicating that tRNA-dependent
editing activity is affected by the mutation of CP1 domain,
because the kobs of AMP formation with tRNA by wild
type hcLeuRS was increased 13-fold than that without
tRNA.
Figure 2. Effect of AN2690 on the aminoacylation and editing properties of hcLeuRS. (A) Aminoacylation of 10mM tRNA
Leu by 25nM hcLeuRS
in the presence (closed square) or absence (closed circle) of AN2690 (100mM). (B) Hydrolysis of 1mM Met-tRNA
Leu by 25nM hcLeuRS (closed
circle), in the presence of 5mM tRNA
Leu (open triangle), or in the presence of 5mM tRNA
Leu and 100mM AN2690 (closed square). Spontaneous
hydrolysis of Met-tRNA
Leu is also presented in the presence of 100mM AN2690 (open circle). (C) AMP formation in the presence or absence
of tRNA (5mM tRNA
Leu) with 100mM AN2690 and 10mM Nva. (D) Graphical representation of the TLC data shown in (C), in the presence
(open circle) or absence (closed circle) of tRNA
Leu.
Figure 3. Effects of the D399A mutation on the editing properties of hcLeuRS. (A) Hydrolysis of Met-tRNA
Leu by 25nM hcLeuRS (closed circle)
and hcLeuRS-D399A (open circle). (B) Production of Met-tRNA
Leu by 1.5mM hcLeuRS (closed circle) and D399A mutant (open circle).
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about 15% of total editing and is nearly equally split
between tRNA-dependent (9% of total editing) and
tRNA-independent (7%) mechanisms. The post-transfer
pathway is far more signiﬁcant, accounting for 84% of
the total editing (Figure 5A).
ABA is mainly edited by pre-transfer editing pathways
To examine if hcLeuRS edits other non-cognate amino
acids using the same editing pathways, the former assays
were repeated in the presence of ABA. ABA generates
toxicity in bacterial cells containing ValRS or LeuRS
deprived of editing activities (42,50). This observation
strongly suggested that ABA was misactivated in vivo
and then transferred onto the corresponding tRNAs
before entering protein synthesis. We assayed the editing
reaction of hcLeuRS in the presence of ABA (Figure 1B);
however, the catalytic efﬁciency of the activation reaction
measured in the ATP–PPi exchange reaction was very low
as compared to Nva, Ile and Met in vitro (Table 3). This
was mainly due to a severe increase of the KM for ABA
that reached 36mM. To bypass this problem, the concen-
tration of ABA was increased to 15mM in the editing
assay. Under these conditions, the AMP formation rate
reached 0.0319s
 1 and 0.0869s
 1 in the absence and the
presence of tRNA, respectively (Table 4). Editing of ABA
disproportionally produced more AMP by the
tRNA-independent pathway, with 37% (3.19/8.69) of
the total editing pathway, compare to Nva editing (7%).
This result suggests hcLeuRS could modulate its
preference of the editing pathways according to the
identity of the amino acid.
The editing assay was also measured in the presence of
AN2690, which inhibits tRNA post-transfer editing. The
AMP formation rates were 0.0347s
 1 and 0.0782s
 1 in
the absence and presence of tRNA, respectively
(Table 4, Supplementary Figure S1). According to these
data, tRNA-dependent pre-transfer editing pathway
contributed 50% [(7.82 3.47)/8.69] to total editing
activity, and post-transfer editing pathway only 10%
[(8.69 7.82)/8.69], showing that hcLeuRS prefers the
pre-transfer editing pathway to edit ABA (Figure 5B).
AMP formation in the presence of ABA was also
assayed with the hcLeuRS-D399A mutant (Figure 4B).
In the absence of tRNA, the editing activities were
decreased compared to the wild-type hcLeuRS
(0.0131s
 1 and 0.0319s
 1, respectively). This decrease of
AMP formation rates by the D399A mutant may be ex-
plained partially by the slight increase of KM for ABA in
the activation rate (Table 3). In the presence of tRNA,
kobs of the AMP formation to edit ABA by
hcLeuRS-D399A increased to 0.0311s
 1. The D399A
mutation destroys post-transfer editing. Because it has
minor effects on tRNA-dependent editing, pre-transfer
editing is more signiﬁcant for ABA.
A signiﬁcant amount of ABA-AMP was formed in the
absence of tRNA with a rate reaching one-tenth of
the AMP formation rate (Figure 1B). In the assay, the
ABA-AMP concentration exceeded the enzyme concentra-
tion, which means that it was released in the solution,
where it was found to be hydrolyzed spontaneously at a
Figure 4. Formation of [
32P]AMP and AA-[
32P]AMP catalyzed by hcLeuRS-D399A. [
32P]ATP, [
32P]AMP, AA-[
32P]AMP were separated by TLC.
Reactions were carried out with (A) Nva and (B) ABA by hcLeuRS-D399A, in the absence (-tRNA
Leu) or presence (+tRNA
Leu) of tRNA
Leu.
The graphs represent the quantiﬁcation of the AMP formation in the presence of tRNA
Leu (open circle) and in its absence (closed circle).
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 4s
 1 (Supplementary Figure S2). This is
considerably lower than the tRNA-independent AMP for-
mation rate (0.0319s
 1). Likewise, when tRNA
Leu was
added to the editing solution, the non-cognate adenylate
did not accumulate, suggesting it was edited through a
process that was tRNA-dependent (Table 4).
Nva-/ABA-tRNA
Leu can be formed by the
hcLeuRS-D399A mutant
Nva and ABA are not commercially available as
radio-labeled compounds, and therefore tRNA
Leu
charging with Nva and ABA cannot be measured by
routine methods. We used a highly sensitive assay to
directly determine formation of Nva-tRNA
Leu and
ABA-tRNA
Leu, which is based on the internal
32P
labeling of the last phosphate linkage of tRNA (40,41).
After aminoacylation of the 30-end
32P-labeled tRNA, the
tRNA was hydrolyzed by the nuclease P1, and the mixture
containing labeled aminoacyl-AMP from charged tRNA
and labeled AMP from uncharged tRNA were separated
by TLC.
HcLeuRS-D399A could catalyze the aminoacylation of
tRNA
Leu with Nva or ABA to form Nva-tRNA or
ABA-tRNA, which were clearly observed on the thin
plate (Figure 6). On the other hand, wild-type
hcLeuRS could only form Leu-tRNA
Leu based on the
fact that the Leu-AMP band but not the ABA-AMP
band was seen on the TLC plate. Furthermore, the
absence of ABA-AMP combined with the data from
Table 4 indicated that native LeuRS could hydrolyze ef-
fectively with either ABA-tRNA or misactivated ABA.
Taken together, these data suggest non-cognate amino
acids such as Nva and ABA could be charged onto
tRNA
Leu when the post-transfer editing function of
hcLeuRS is destroyed, which is consistent with the
previous in vivo results in E. coli (43,50,51). For ABA
editing, although the pre-transfer pathway is dominant,
the post-transfer pathway is still necessary to prevent the
mischarge by hcLeuRS.
DISCUSSION
The hcLeuRS and hctRNA
Leu expressed in E. coli provide
an efﬁcient system for studying hcLeuRS function
In mammalians, cytoplasmic LeuRS is one of the eight
components of the MSC. The properties of hcLeuRS
have only been partially studied previously. Our lab had
reported on the expression and puriﬁcation of recombin-
ant hcLeuRS from insect cells (33). This hcLeuRS was
shown to have high speciﬁc activity and its C-terminal
extension was crucial for the interaction with the
N-terminal extension of hcArgRS (33). In order to
further evaluate the editing properties of hcLeuRS, we
simpliﬁed its expression and puriﬁcation method. The
present preparation was obtained from E. coli
transformants and puriﬁed by afﬁnity chromatography
on a Ni
2+-NTA column. As compared with the previous
preparation from the baculovirus system, its activities of
Figure 5. Summary of the relative contributions of the different editing pathways used by hcLeuRS to edit Nva and ABA. HcLeuRS edits (A) Nva
predominantly by post-transfer editing while uses mainly pre-transfer editing to edit (B) ABA. The global editing activity was measured as AMP
formation in the presence of tRNA. The contribution of the tRNA-independent pre-transfer editing was measured in the absence of tRNA. The
contribution of the tRNA-dependent pre-transfer editing was deduced from the AMP formation measured in the presence of the AN2690 compound.
The post-transfer editing accounted for the left in the global editing.
Figure 6. Aminoacylation of hctRNA
Leu with Leu, Nva and ABA per-
formed by the hcLeuRS or hcLeuRS-D399A. Aminoacylations were
carried out with 5mM
32P-labeled hctRNA
Leu, 5mM Leu or 10mM
Nva or 15mM ABA by 1.5mM hcLeuRS-D399A or 500nM
hcLeuRS, respectively. AMP (from uncharged tRNA) and
aminoacyl-AMP (from aminoacyl-tRNA) after nuclease P1 digestion
of aminoacylation reactions were separated by TLC.
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Leu
transcript were considerably improved by the rapid
protocol and the optimal Mg
2+/ATP ratio. HcLeuRS
had exceptionally high charging catalytic efﬁciency with
hctRNA
Leu purifed from E. coli overproducing strain, and
was 8-fold higher than that of the tRNA
Leu transcript
(Table 1). Transfer RNAs are involved in translation of
the genetic code as well as gene expression regulation
(52,53). It has been known for a long time that modiﬁed
bases of tRNA are very important for tRNA structure and
function (54–57). Modiﬁed bases may constrain the tRNA
structure (55) and provide interacting groups with the
enzyme (58–60). Human cytoplasmic tRNA
Leu isolated
from E. coli transformants exhibited higher thermal sta-
bility, higher accepting capacity, and although we did not
study tRNA structure directly, this could be due to the
modiﬁcation of some nucleotides during expression. Thus,
our present hcLeuRS and hctRNA
Leu isolated from E. coli
transformants provide an efﬁcient system to study the
function and tertiary structure of hcLeuRS, which will
be helpful in designing novel selective antibiotics
targeted to the synthetic and editing active sites of
LeuRSs from pathogenic bacteria.
HcLeuRS misactivates Nva and ABA
LeuRS is closely related to IleRS and ValRS, belonging to
the LIV-RS subgroup of class Ia synthetases (1). Leu, Ile
and Val are hydrophobic amino acids that differ slightly.
Incidentally, when misactivation errors occur, IleRS must
eliminate the non-cognate amino acid valine (10). ValRS
edits the non-cognate, isosteric threonine, which only
differs by a hydroxyl group (12) and LeuRS has to dis-
criminate leucine from isoleucine and methionine that are
mischarged on tRNA
Leu (14). In addition to these amino
acids, various non-protein amino acids are activated by
LeuRS (13). Here, the activation properties of hcLeuRS
for two non-protein amino acids were studied. First, Nva
was chosen since this compound is naturally found in vivo
(61,62), and can be incorporated into proteins (51).
Compared to Leu, Nva differs by the absence of a single
methyl group and consequently was misactivated by
hcLeuRS with a loss of catalytic efﬁciency of only
100-fold compared with Leu (Table 3). This loss was
mainly due to a KM effect corresponding to a binding
energy variation of only 2.7kcal/mol, which is consistent
with the loss of van der Waals forces expected from inter-
action of a methyl group with a hydrophobic binding site.
HcLeuRS and E. coli or A. aeolicus LeuRSs exhibited
nearly the same binding energy variation (19,28), suggest-
ing that Nva binds and reacts with the three enzymes in a
similar way.
In parallel, ABA misactivation by LeuRS was analyzed.
ABA has been shown to generate toxicity in E. coli cells
exhibiting ValRS and LeuRS deprived of editing activities
(42,50), which suggests ABA was misactivated before
being charged on tRNA
Leu and subsequently incorporated
into proteins. Therefore, the activation of ABA by
hcLeuRS was investigated. As ABA is smaller than Leu
and Nva, it was predicted that there should be no steric
hindrance to the active site of LeuRS. Indeed, the kcat of
hcLeuRS for ABA in activation reaction was reduced, but
remained in the same order of magnitude as the kcat for
Leu. On the other hand, the KM for ABA was increased by
800-fold for Leu, which indicated that part of the binding
energy was lost during binding of the smaller molecule
(5kcal/mol). Altogether, these results suggest Nva and
ABA could potentially be activated by hcLeuRS in vivo,
especially when concentrations of these compounds are
high, and therefore may require editing mechanisms to
clear the misactivated or mischarged products.
Nva is preferentially edited by post-transfer editing
pathway
The present study showed that hcLeuRS used several
editing pathways to exclude the wrong products. The
tRNA-dependent editing pathways formed the highest
amounts of AMP (93%), whereas the tRNA-
independent editing pathways only accounted for 7% of
the AMP formation calculated from the kinetic param-
eters in Table 4. Basically, the tRNA-dependent editing
pathways include tRNA-dependent pre-transfer and
post-transfer editing (19). The tRNA-independent
editing pathways group tRNA-independent pre-transfer
pathway and spontaneous hydrolysis of non-cognate
after release in solution. Thanks to the recently developed
antifungal drug AN2690, it was possible to inhibit specif-
ically the post-transfer editing reaction and isolate the
tRNA-dependent pre-transfer editing reaction (46,47). In
this way, the tRNA-dependent pre-transfer editing
reaction was found to account for 9% of the total AMP
formation, a value close to the tRNA-independent
pre-transfer editing that was measured in the absence of
tRNA (7%). These two reactions were rather low
compared to the post-transfer editing, which contributed
to about 84% of the AMP formation to edit Nva. The last
pathway, non-enzymatic hydrolysis or ‘kinetic proofread-
ing’ (30,63), was measured by inducing a chase with ATP.
According to previous studies of LeuRSs (19,28), this
pathway is also a minor editing pathway for hcLeuRS
(Supplementary Figure S2) and contributed to <1% of
the total AMP formation rate. It is likely that the partition
of the editing activities in three main pathways is not static
but follows changes and adaptations to the physiological
conditions. Herein, the quantiﬁcation of each pathway
was obtained by shutting down the other pathways by
different methods (D399A mutation in the editing site,
AN2690 compound and the absence of tRNA). It is
possible that in response to the suppression of one
editing pathway the other might have been activated as
suggested earlier (64). Overall, these percentages should
not be regarded as deﬁnitive values, but they highlight
the enzyme resources to get rid of incorrect intermediates
or products.
ABA is mainly edited by pre-transfer editing mechanisms
The AMP formation assays performed in the presence of
ABA were only weakly stimulated by tRNA
Leu compared
to similar assays performed with Nva. In the presence of
tRNA and AN2690, which targeted the post-transfer
editing reaction, the AMP formation rate was slightly
244 Nucleic Acids Research, 2011,Vol. 39,No. 1decreased when compared with the reaction without
AN2690 (0.0782 versus 0.0869s
 1). This suggests that
when post-transfer editing pathway of hcLeuRS is
blocked by AN2690, tRNA-dependent pre-transfer
editing pathway is the exclusive contributor to ABA
editing. Moreover, we can estimate that the post-transfer
pathway accounts for only 10% of the editing. Here, we
showed that ABA can be activated by hcLeuRS to form
ABA-AMP (Figure 1B). In addition, we used a sensitive
assay to determine the mis-charged products (Nva- or
ABA-tRNA
Leu) based on the labeling of the 30-last phos-
phate of tRNA
Leu by tRNA nucleotidyltransferase. The
data showed that Nva and ABA can be charged on the
tRNA by the editing-defective but not native enzyme
(Figure 6), because hcLeuRS-D399A decreased the
activity to edit Nva and ABA. Although post-transfer
editing activity to edit ABA represents only 10% of total
editing activity of the native hcLeuRS, this activity is high
enough to deacylate ABA. In contrast, hcLeuRS-D399A
is deprived of post-transfer editing and accumulates
ABA-tRNA. The results suggested that post-transfer
editing is the last but crucial checkpoint for maintaining
the ﬁdelity of aminoacylation of aaRSs, even if it only
contributes to a minor part of the total editing activity.
For this reason, the post-transfer editing is essential and a
slight decrease of this editing activity may affect the
aminoacylated products synthesized by aaRSs. It has
been shown that cellular accumulation of mis-charged
products induces mistranslation and then cell death,
causing diseases such as neurodegeneration (65,66).
Adaptation of enzyme editing properties to distinct
misactivated products
Our present study showed that the editing properties of an
enzyme are not frozen but can vary considerably accord-
ing to the compound to be edited. With Nva, hcLeuRS
exhibited a clear preference for post-transfer editing.
However, with ABA, the enzyme used mainly pre-transfer
editing. These different preferences for editing
non-cognate compounds highlighted the modular charac-
ter of the editing pathways of aaRS.
Pre- and post-transfer editing reactions are usually con-
sidered as the clearing mechanisms for the amino acid
activation and aminoacylation reactions, respectively.
We can reasonably assume that a misactivated
compound can be edited by the pre-transfer mechanism
or released from the enzyme (kinetic proofreading) ﬁrst.
The non-cognate activated amino acid can also be charged
to produce misacylated-tRNA and be deacylated in a
special editing domain by the post-transfer pathway.
Therefore, the preference given by an enzyme to a
pathway would directly depend on the capacity of the
non-cognate amino acids to be activated and charged,
and its capacity to be eliminated at different editing check-
points (19,28,30,67–69). Pre-steady state kinetics per-
formed on class I Ile- and ValRS and class II ThrRS
have recently conﬁrmed that the contribution of pre-
and post-transfer editing are subjected to modulation by
the rate of aminoacyl transfer (70), leading to the concept
of kinetic partitioning between the two pathways (71).
Therefore, the use of pre-steady state kinetics with differ-
ent non-cognate amino acids may help to establish which
of the different editing pathways is the preferred pathway
(70).
The post-transfer editing mechanism is relatively well
known and accepted, while the different pre-transfer
editing mechanisms are actively discussed. The precise lo-
cation(s) of the pre-transfer editing site and the function(s)
of tRNA are uncertain, oscillating between the sites
located on CP1 editing domain (15,48,72–74) or on the
synthetic domain (24,31,75). Herein, the AMP formation
rates of the native hcLeuRS in the presence of AN2690
and tRNA showed that a tRNA-dependent pre-transfer
editing reaction still exists when the tRNA is blocked in
an inactive conformation into the CP1 editing site. This
result suggests that the tRNA-dependent pre-transfer
editing reaction occurs more likely into the synthetic site
as the CP1 editing site is bound by AN2690. The editing
properties of mutant D399A also support this conclusion.
Although the post-transfer editing of the mutant was lost,
the presence of tRNA stimulated ABA editing as expected
from the tRNA-dependent pre-transfer editing reaction.
Altogether, these data strongly suggest that the synthetic
active site also contains the editing site where the
tRNA-dependent pre-transfer editing catalysis occurs.
In conclusion, our data suggest that pre-transfer editing
preferentially targets some non-cognate amino acids,
whereas post-transfer editing is more efﬁcient with other
structurally related non-cognate amino acids. The prefer-
ence could result from the capacity of the non-cognate
amino acids to be charged onto the tRNA. This might
explain that hcLeuRS favored post-transfer editing with
Nva and pre-transfer editing with ABA. We are currently
studying the editing properties of hcLeuRS for various
non-cognate amino acids in order to conﬁrm this result.
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